Sigma Healthcare Limited (ASX: SIG)
Australia
· Delayed Price · Currency is AUD 2.550
+0.130 (5.37%)
Nov 22, 2024, 4:10 PM AEST
Sigma Healthcare Income Statement
Financials in millions AUD. Fiscal year is February - January.
Millions AUD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 | 2019 - 2015 |
| Revenue | 3,481 | 3,322 | 3,660 | 3,446 | 3,400 | 3,244 | Upgrade
|
| Revenue Growth (YoY) | -0.72% | -9.24% | 6.21% | 1.35% | 4.81% | -18.42% | Upgrade
|
| Cost of Revenue | 3,253 | 3,104 | 3,406 | 3,208 | 3,161 | 3,029 | Upgrade
|
| Gross Profit | 227.81 | 218.14 | 254.41 | 237.95 | 239.19 | 215.02 | Upgrade
|
| Selling, General & Admin | 266.75 | 253.57 | 293 | 309.6 | 309 | 288.93 | Upgrade
|
| Other Operating Expenses | -81.9 | -95.15 | -95.18 | -103.31 | -109.04 | -99.25 | Upgrade
|
| Operating Expenses | 211.94 | 186.74 | 228.15 | 233.99 | 228.54 | 216.94 | Upgrade
|
| Operating Income | 15.87 | 31.4 | 26.26 | 3.96 | 10.65 | -1.92 | Upgrade
|
| Interest Expense | -13.18 | -16.3 | -14.41 | -10.84 | -11.83 | -13.44 | Upgrade
|
| Interest & Investment Income | 8.22 | 1.72 | 0.6 | 0.22 | 0.36 | 0.74 | Upgrade
|
| EBT Excluding Unusual Items | 10.91 | 16.82 | 12.45 | -6.66 | -0.81 | -14.62 | Upgrade
|
| Merger & Restructuring Charges | -8.2 | -8.2 | - | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | -6.99 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -1.65 | 29.37 | -1.14 | Upgrade
|
| Pretax Income | 2.71 | 8.62 | 5.46 | -8.31 | 28.56 | -15.76 | Upgrade
|
| Income Tax Expense | 4.86 | 3.31 | 2.44 | -1.97 | -16.46 | -4.29 | Upgrade
|
| Earnings From Continuing Operations | -2.15 | 5.31 | 3.03 | -6.34 | 45.02 | -11.47 | Upgrade
|
| Minority Interest in Earnings | -0.86 | -0.8 | -1.22 | -0.9 | -1.49 | -0.86 | Upgrade
|
| Net Income | -3 | 4.51 | 1.81 | -7.24 | 43.53 | -12.33 | Upgrade
|
| Net Income to Common | -3 | 4.51 | 1.81 | -7.24 | 43.53 | -12.33 | Upgrade
|
| Net Income Growth | - | 148.98% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 1,443 | 1,024 | 990 | 988 | 986 | 975 | Upgrade
|
| Shares Outstanding (Diluted) | 1,443 | 1,063 | 1,015 | 1,027 | 1,018 | 975 | Upgrade
|
| Shares Change (YoY) | 25.15% | 4.75% | -1.13% | 0.88% | 4.41% | -3.57% | Upgrade
|
| EPS (Basic) | -0.00 | 0.00 | 0.00 | -0.01 | 0.04 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.00 | 0.00 | 0.00 | -0.01 | 0.04 | -0.01 | Upgrade
|
| EPS Growth | - | 118.82% | - | - | - | - | Upgrade
|
| Free Cash Flow | -69.43 | 37.25 | 106.59 | -60.49 | -64.56 | 145.61 | Upgrade
|
| Free Cash Flow Per Share | -0.05 | 0.04 | 0.11 | -0.06 | -0.06 | 0.15 | Upgrade
|
| Dividend Per Share | 0.010 | 0.010 | 0.010 | 0.020 | 0.010 | 0.010 | Upgrade
|
| Dividend Growth | 0% | 0% | -50.00% | 100.00% | 0% | -71.43% | Upgrade
|
| Gross Margin | 6.54% | 6.57% | 6.95% | 6.90% | 7.03% | 6.63% | Upgrade
|
| Operating Margin | 0.46% | 0.95% | 0.72% | 0.11% | 0.31% | -0.06% | Upgrade
|
| Profit Margin | -0.09% | 0.14% | 0.05% | -0.21% | 1.28% | -0.38% | Upgrade
|
| Free Cash Flow Margin | -1.99% | 1.12% | 2.91% | -1.76% | -1.90% | 4.49% | Upgrade
|
| EBITDA | 29.36 | 45.78 | 41.8 | 18 | 25.35 | 10.95 | Upgrade
|
| EBITDA Margin | 0.84% | 1.38% | 1.14% | 0.52% | 0.75% | 0.34% | Upgrade
|
| D&A For EBITDA | 13.49 | 14.38 | 15.54 | 14.04 | 14.7 | 12.87 | Upgrade
|
| EBIT | 15.87 | 31.4 | 26.26 | 3.96 | 10.65 | -1.92 | Upgrade
|
| EBIT Margin | 0.46% | 0.95% | 0.72% | 0.11% | 0.31% | -0.06% | Upgrade
|
| Effective Tax Rate | 179.20% | 38.42% | 44.58% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.